Insulin degludec's ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes
Year: 2014
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Pediatric Diabetes
DOI: 10.1111/pedi.12116
Institutions: Kinderkrankenhaus auf der Bult, Novo Nordisk (Denmark)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Sanofi
OpenAlex ID: W1709260067